A detailed history of Mariner, LLC transactions in Staar Surgical CO stock. As of the latest transaction made, Mariner, LLC holds 16,321 shares of STAA stock, worth $390,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,321
Previous 17,168 4.93%
Holding current value
$390,561
Previous $817,000 25.83%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$29.97 - $47.42 $25,384 - $40,164
-847 Reduced 4.93%
16,321 $606,000
Q2 2024

Aug 13, 2024

BUY
$38.07 - $52.25 $15,837 - $21,736
416 Added 2.48%
17,168 $817,000
Q1 2024

May 15, 2024

BUY
$27.67 - $39.61 $19,756 - $28,281
714 Added 4.45%
16,752 $641,000
Q4 2023

Feb 14, 2024

SELL
$30.6 - $43.78 $12,515 - $17,906
-409 Reduced 2.49%
16,038 $500,000
Q3 2023

Nov 13, 2023

SELL
$39.39 - $58.12 $4,569 - $6,741
-116 Reduced 0.7%
16,447 $660,000
Q2 2023

Aug 11, 2023

SELL
$50.45 - $72.82 $13,066 - $18,860
-259 Reduced 1.54%
16,563 $870,000
Q1 2023

May 12, 2023

BUY
$51.25 - $79.34 $22,345 - $34,592
436 Added 2.66%
16,822 $1.08 Million
Q4 2022

Feb 14, 2023

SELL
$46.82 - $76.2 $24,440 - $39,776
-522 Reduced 3.09%
16,386 $795,000
Q3 2022

Nov 10, 2022

BUY
$70.55 - $111.58 $19,471 - $30,796
276 Added 1.66%
16,908 $1.19 Million
Q2 2022

Aug 15, 2022

BUY
$50.24 - $80.48 $22,457 - $35,974
447 Added 2.76%
16,632 $1.18 Million
Q1 2022

May 13, 2022

BUY
$57.98 - $93.5 $40,759 - $65,730
703 Added 4.54%
16,185 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$88.02 - $127.79 $16,899 - $24,535
192 Added 1.26%
15,482 $1.41 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $162.68 $1.88 Million - $2.49 Million
15,290 New
15,290 $1.97 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.15B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.